[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Integumen Plc LSE:SKIN London Ordinary Share GB00BMGWZY29 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 28.00 28.00 29.00 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Personal Goods 0.8 -2.4 0.3 93.3 32

Deepverge PLC Microtox Successful Phase 3 Field Trials

24/06/2021 7:00am

UK Regulatory (RNS & others)


Integumen (LSE:SKIN)
Historical Stock Chart


From Mar 2021 to Sep 2021

Click Here for more Integumen Charts.

TIDMDVRG

RNS Number : 9129C

Deepverge PLC

24 June 2021

24 June 2021

DeepVerge plc

("DeepVerge" or the "Company")

Microtox(R) PD claims world first live data alerts of SARS-Cov-2 in wastewater treatment plants

Modern Water enters Service Agreement with EPS Group for European Microtox (R) PD [i] installations

DeepVerge (LSE:DVRG.L), today announces the successful completion of Phase 3 field trials in which Microtox(R) PD achieved real-time detection and transmission of data, specific to SARS-CoV-2, in wastewater treatment plants at multiple sites [ii] . As a result, its Environmental Health Division ("Modern Water") has entered into a master service agreement with EPS Group to install, calibrate, service and maintain Microtox (R) PD units which, subject to negotiation with undisclosed parties, have the potential to be installed in multiple European countries.

Gerard Brandon, DeepVerge plc CEO commented:

"The successful completion of the Phase 3 field trials clearly demonstrates the capability and value of Microtox(R) PD to identify dangerous pathogens, including SARS-CoV-2, in real-time. By establishing a permanent anonymised mass surveillance of wastewater, DeepVerge claims a world first real-time defence against this global pandemic. The installation of Microtox(R) PD wastewater units will enable live data to simultaneously identify the source of COVID-19 cases as well as identify COVID-19 clusters with the ability to indicate the size of each cluster. As the data grows, the central AI system has the potential to predict the trajectory of growth of future clusters of SARS-CoV-2 or any future dangerous pathogen .

"Having achieved this major milestone, we are delighted to enter this agreement with EPS Group who complete the final step of installing, retrofitting and maintaining our Microtox(R) PD equipment. With this level of established technical engineering support and distribution, DeepVerge can now offer an end-to-end solution for public and private clients across the European wastewater sector. We expect updates from our Joint Venture agreement with China Resources and roll-out in the US to follow early in Q3. "

Patrick Buckley, EPS Group Managing Director commented:

"We are very pleased to be part of this innovative partnership with DeepVerge to help combat the pandemic with their unique Microtox(R) PD technology playing a crucial role in the early detection of COVID-19 hotspots around the world. With 550 personnel, our largest footprint in the water, wastewater pumping and treatment services sector across Europe, EPS Group engineers are ready to make this happen".

Background to field trials:

On the 24 September 2020, the Company announced [iii] completion of the integration of an Affimer/Aptamer-based real-time SARS-CoV-2 detector and alert system into Modern Water's Microtox water contamination system, now called Microtox(R) PD , for the detection of the coronavirus in wastewater. Microtox(R) PD successfully completed initial spike protein testing and validation of SARS-CoV-2 in filtered wastewater and transitioned to the University of Aberdeen for full beta testing of the system using real SARS-CoV-2 virus samples in its containment level 3 laboratory, prior to initiation of the field trials, referred to above.

Contacts

 
                                                   +44 (0) 7340 055 
 DeepVerge plc              Gerard Brandon, CEO     648 
 SPARK Advisory Partners 
  Limited                   Neil Baldwin/Andrew    +44 (0) 113 370 
  (Nominated Adviser)        Emmott                 8974 
 Turner Pope Investments    Andy Thacker/James     +44 (0) 20 3657 
  (TPI) Limited (Broker)     Pope                   0050 
 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

About EPS Group (www.epswater.ie)

EPS Group is one of largest, privately owned Design-Build-Operate European partners for the delivery, operation and concession management of water and wastewater assets. A wet infrastructure specialist, employing approximately 550 people with revenues in excess of GBP100m. With a 52 year pedigree, EPS has grown from a modest electrical and pumping services business into an innovative, internationally exporting product and service provider, focused on water, wastewater and clean technology.

EPS Group work across the utility; industrial; commercial; residential and agricultural sectors with customers as varied as water and power companies; those in the dairy, meat processing, bakery, brewing and distilling industries; pharmaceuticals, biotechnology, microelectronic, data centre and defence spaces to commercial including building services, leisure, office/retail outlets and SMEs to residential and agricultural clients.

[i] Microtox (R) PD has been designed to be retrofitted into existing Modern Water equipment to detect and identify a range of infectious viruses and bacteria including SARS-CoV-2, E.coli, Legionella and Cryptosporidium, on a single chip, using AI, in real-time.

[ii] First deployments of Microtox(R) PD Microtox(R) PD

https://irpages2.equitystory.com/websites/rns_news/English/1100/news-tool---rns---eqs-group.html?iframe=true&article=31443290&company=Deepverge&iframe=true

[iii] COVID-19 wastewater Microtox ready for beta testing https://irpages2.equitystory.com/websites/rns_news/English/1100/news-tool---rns---eqs-group.html?iframe=true&article=31216869&company=Deepverge&iframe=true

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCSEDFWDEFSEFM

(END) Dow Jones Newswires

June 24, 2021 02:00 ET (06:00 GMT)

1 Year Integumen Chart

1 Year Integumen Chart

1 Month Integumen Chart

1 Month Integumen Chart
ADVFN Advertorial
Your Recent History
LSE
SKIN
Integumen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210925 19:50:51